Abioclav

Active substance

Amoxicillin and clavulanic acid

Strenght and pharmaceutical forms

875 mg+125 mg film-coated tablets - 12 tablets
400 mg+57 mg/5 ml powder for oral suspension - bottle 70 ml

ATC

J01CR02 - Combinations of penicillins, included beta-lactamase inhibitors

Therapeutic Indications

ABIOCLAV is indicated for the treatment of the following infections in adults and children:
• Acute bacterial sinusitis (adequately diagnosed)
• Acute otitis media
• Acute exacerbations of chronic bronchitis (adequately diagnosed)
• Community acquired pneumonia
• Cystitis
• Pyelonephritis
• Skin and soft tissue infections in particular cellulitis, animal bites, severe dental abscess with spreading cellulitis
• Bone and joint infections, in particular osteomyelitis

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.